FDA Draft Guidance on Expansion Cohorts – Read IDDI Comments
FDA Draft Guidance on the Use of Expansion Cohorts in first-in-human clinical trials IDDI has submitted a comment on the Food and Drug Administration (FDA) recent Draft Guidance for Industry regarding the use of expansion cohorts in first-in-human clinical trials. With […]